﻿<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
<channel rdf:about="http://medrxiv.org">
<admin:errorReportsTo rdf:resource="mailto:medrxiv@cshlpress.edu"/>
<title>medrxiv Subject Collection: All</title>
<link>http://medrxiv.org</link>
<description>
This feed contains articles for medRxiv Subject Collection "All"
</description>

<items>
<rdf:Seq>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357065v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357045v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26355859v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.03.26357002v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26357103v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26356762v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357043v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26357095v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26356192v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26357097v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26356954v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357034v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357080v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26357105v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26357096v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26357125v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357063v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357066v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26356561v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357053v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26356511v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26357104v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357075v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357006v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26356352v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26357101v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.02.26357123v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357062v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.07.01.26357068v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.06.25.26356547v1?rss=1"/>
</rdf:Seq>
</items>
<prism:eIssn/>
<prism:publicationName>medrxiv</prism:publicationName>
<prism:issn/>

<image rdf:resource=""/>
</channel>
<image rdf:about="">
<title>medrxiv</title>
<url>https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png</url>
<link>http://medrxiv.org</link>
</image>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357065v1?rss=1">
<title>
<![CDATA[
Epidemiology of antimicrobial use in Malawi: a cross-sectional study using World Health Organisation core antimicrobial use indicators in faith-based health facilities 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357065v1?rss=1
</link>
<description><![CDATA[
Background : Antimicrobial resistance (AMR) is a major public health threat globally, with a disproportionate burden in sub-Saharan Africa. Faith-based health facilities provide essential healthcare services to underserved populations, yet data on antimicrobial use in these settings remain limited.   Aim : To assess antimicrobial use in Christian Health Association of Malawi health facilities using the World Health Organisation core medicine use indicators.   Materials and Methods : A multicentre cross-sectional study was conducted in 29 CHAM health facilities across Malawi between January 2024 and June 2025. Data were collected from facility personnel, inpatient prescriptions, and patient interviews and analysed using descriptive and inferential statistics.   Results : Average availability of key antimicrobials was 33.1% (95% CI: 29.7-36.4), while customised formularies were available in 64.3% of health facilities. Among 660 prescriptions analysed, 90.3% contained an antimicrobial agent, but only 33.2% adhered to standard treatment guidelines and 43.6% were prescribed using full generic names. Facilities with pharmacy professionals were more likely to have a facility-specific formulary (84.6% vs. 46.7%, p = 0.037).   Conclusion : Antimicrobial stewardship gaps remain substantial in faith-based health facilities in Malawi and across sub-Saharan Africa, highlighting the need for targeted stewardship programmes in faith-based health facilities.
]]></description>
<dc:creator><![CDATA[ Chirambo, E. C., Chiumia, F. K., Nkhoma, D. E., Mitambo, C., Thawani, A., Msiska, T. L., Odeo, S., Asin, J., John, M., Chuaikan, W., Angwe, M., Khomani, P., Chibwe, I., Matchado, S., Chimwaza, C., Matchere, P., Chiweza, B., Mwenyekonde, E., Kampira, E. K., Kamanga, E., Salima, Z., Banda, C. G., Makala, H. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357065</dc:identifier>
<dc:title><![CDATA[Epidemiology of antimicrobial use in Malawi: a cross-sectional study using World Health Organisation core antimicrobial use indicators in faith-based health facilities]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357045v1?rss=1">
<title>
<![CDATA[
A simplified antigen-based serological algorithm accurately classifies MPXV exposure and vaccination status 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357045v1?rss=1
</link>
<description><![CDATA[
Reliable serological tools are needed to measure mpox virus (MPXV) exposure, evaluate vaccine-induced immunity, and support population-level surveillance. Using a previously established six-antigen serological reference framework, in which seropositivity was defined as reactivity to [&ge;]4 of 6 MPXV antigens, we evaluated the diagnostic performance of individual antigens and all 15 pairwise combinations. B6R demonstrated the highest overall individual discriminatory performance, whereas A35R showed maximal sensitivity and M1R the highest specificity. The A35R+B6R combination most closely approximated the full multiplex assay (AUC 0.93), supporting simplified, scalable MPXV serological assays for surveillance and vaccine evaluation.
]]></description>
<dc:creator><![CDATA[ Abdullahi, A., Adebisis, G., Wisso, H., Osawe, S., Kampmann, B., Abimiku, A., Gupta, R. K. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357045</dc:identifier>
<dc:title><![CDATA[A simplified antigen-based serological algorithm accurately classifies MPXV exposure and vaccination status]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26355859v1?rss=1">
<title>
<![CDATA[
Human In the Loop Challenges for Quality Annotation of Pre-Cancer Lesions in Clinical Oral Images 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26355859v1?rss=1
</link>
<description><![CDATA[
Background: The hyperplasia and dysplasia stage (pre-cancer) offers a viable opportunity to reduce the incidence and mortality of oral cancer through early prevention. Smartphone-based Artificial Intelligence (AI) enabled screening of potentially malignant oral lesions offers a scalable solution for this in resource-constrained settings. However, developing accurate and explainable AI segmentation models require high-quality, pixel-level annotated data. This process that is prohibitively expensive, time-consuming, and prone to inter-observer subjectivity among clinical experts. Methods: We designed and empirically validated a Deep Learning-driven Human-in-the-Loop (HITL) framework to pixel-annotate a dataset of 3026 clinical oral images. Using an iterative pseudo-labeling pipeline, we evaluated the model's learning dynamics and performance evolution across five training cycles. We conducted controlled experiments to quantify the networks tolerance to intermediate level of label noise (unreviewed pseudo-labels) to resolve clinical subjectivity using pixel-wise Cohen's Kappa and the STAPLE consensus algorithm. Results: Iterative self-training produced sustained improvements in lesion detection and spatial localization. However, controlled experiments revealed that including even a modest fraction ({approx}10%) of unreviewed pseudo-labels led to a three-to-four-fold increase in training convergence instability and induced a conservative prediction bias that negatively impacted model recall. When measured against multi-expert ground truth, the model's performance converged with the inter-rater reliability ceiling ({kappa} {approx} 0.65), indicating that its predictions fell within the envelope of human agreement. Conclusions: Our findings emphasize that a final expert-driven quality assurance step remains absolutely essential to mitigate training instability, confirmation bias, and clinically unacceptable drops in recall caused by label noise. Overall, this work provides a scalable, empirically validated blueprint for building domain-specific medical imaging datasets in low-resource global health settings, where the dual challenges of annotation cost and inter-observer variability are most acute.
]]></description>
<dc:creator><![CDATA[ Mandal, S., Mendonca, P., Gurushanth, K., Thakur, H., Birur, P., Shetty, A., Pal, D. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26355859</dc:identifier>
<dc:title><![CDATA[Human In the Loop Challenges for Quality Annotation of Pre-Cancer Lesions in Clinical Oral Images]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.03.26357002v1?rss=1">
<title>
<![CDATA[
Gut microbiome signatures associated with self-reported allergic symptoms among Finnish adults 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.03.26357002v1?rss=1
</link>
<description><![CDATA[
Background Growing evidence suggests that the gut microbiome influences nasal and ocular allergic inflammation through gut-mucosal immune interactions. Yet, its association with Allergic rhinitis (AR) and allergic eye symptoms (AES) remains incompletely understood in large population-based cohorts. Objective To examine associations between the gut microbiome and self-reported AR and AES in Finnish adults. Methods Shallow metagenomic sequencing was performed on stool samples from a population-based cohort (FINRISK02; n = 7,231). Microbial taxonomic and functional profiles were compared between individuals with AR (n = 1,950), AES (n = 1,554), combined allergies (AR and/or AES; n = 2,305), and controls without reported symptoms (n = 3,175). Results Allergic groups exhibited lower microbial richness and phylogenetic diversity than controls. Shared microbial and functional signatures were observed across AR and AES, consistent with their high co-occurrence (N = 1,199). Compared with controls, allergic groups showed enrichment of 17 bacterial species, predominantly from the Clostridia class, including taxa previously associated with asthma, chronic obstructive pulmonary disease, and atopic dermatitis. Allergic individuals also exhibited enrichment of pathways related to mucosal carbohydrate processing, shikimate metabolism, histidine turnover, and broader amino acid metabolism. Concurrent enrichment of histidine biosynthesis and degradation suggested altered microbial histidine metabolism. Conclusions Adult allergic symptoms are associated with gut microbiome taxonomic and functional alterations linked to mucosal barrier function and immune-related metabolism, supporting a shared gut-mucosal immune axis across allergic phenotypes.
]]></description>
<dc:creator><![CDATA[ Lindgren, H. H., Vartiainen, V., Muluh, G., Bayal, N., Parnanen, K., Meric, G., Jousilahti, P., Ruuskanen, M. O., Knight, R., Niiranen, T., Havulinna, A., Salomaa, V., Erawijantari, P. P., Lahti, L. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.03.26357002</dc:identifier>
<dc:title><![CDATA[Gut microbiome signatures associated with self-reported allergic symptoms among Finnish adults]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26357103v1?rss=1">
<title>
<![CDATA[
Predictors of carried ESBL-producing Enterobacterales involvement in ICU-acquired infection: insights from a bicentric retrospective cohort study. 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26357103v1?rss=1
</link>
<description><![CDATA[
Rationale: Infections due to Extended-spectrum {beta}-lactamases-producing Enterobacterales (ESBL-PE) require empirical treatment with carbapenems. ESBL-PE carriage is considered as a risk factor for ESBL-PE involvement during ICU infection. Our aim was to determine factors that may predict the actual involvement of ESBL-PE. Methods: A two-periods bicentric ambispective study including ICU ESBL-PE carriers patients from April 2011 to January 2019. All ESBL-PE carriers who developed an infection were analyzed. Results: 6112 patients and 4902 patients were screened during the two periods. 384 and 232 ESBL-PE carriers were identified. Total number of infectious episodes were 146 and 114, respectively. A total of 144 pneumonias, 42 urinary tract infection and 45 digestive infections were studied. An ESBL-PE was involved in 35 (24.3%) episodes of pneumonia, and 44 (37.9%) of extra-pulmonary infections. The most frequent ESBL-PE involved were K. pneumoniae, E. cloacae and E. coli. Similar species and phenotypes were present in colonisation and infection in 29 (82.8%) of pneumonia and in 40 (90.9%) of extra-respiratory infection. Multivariate analysis identified Klebsiella pneumonia or Enterobacter cloacae carriage as risk factor for ESBL-PE involvement in pneumonia and E. coli carriage and detection of ESBL-PE carriage before ICU admission as protective factors. Conclusion: In our study an ESBL-PE involvement is infrequent in pneumonia. A known carriage before ICU admission and E. coli carriage are factors associated with the absence of ESBL-PE un the episode of respiratory infection. A confirmation of our findings could lead to a reduction in the empirical use of carbapenems in this population.
]]></description>
<dc:creator><![CDATA[ Schimpf, C., Soussan, R., de Boissieu, P., Quesnel, C., Philippart, F. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26357103</dc:identifier>
<dc:title><![CDATA[Predictors of carried ESBL-producing Enterobacterales involvement in ICU-acquired infection: insights from a bicentric retrospective cohort study.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26356762v1?rss=1">
<title>
<![CDATA[
Impact of wildfire-related fine particulate matter on tuberculosis notifications in Brazil: a nationwide panel study, 2003-2023 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26356762v1?rss=1
</link>
<description><![CDATA[
Background Wildfire activity and smoke exposure are increasing worldwide because of climate and land-use change. Although fine particulate matter (PM2.5) may impair pulmonary immune defences against tuberculosis (TB), population-level evidence remains limited. We estimated the effect of wildfire-related PM2.5 exposure on TB notification rates in Brazil. Methods We conducted a nationwide panel study linking municipality-level monthly TB notifications from Brazil's SINAN system with wildfire-related PM2.5 estimates from GEOS-Chem simulations across 5,545 municipalities (2003-2023). We estimated the impact of high-exposure days (PM2.5 > 25 g/m3) on monthly TB notifications using Poisson regression with fixed effects for municipalities, state-by-year, and state-by-month, controlling for time-invariant differences, secular trends, and seasonality. Distributed lag effects were estimated over 1-24 months before notification. Models accounted for meteorological conditions, GeneXpert diagnostic coverage, and spatial correlation using Conley standard errors. We computed attributable fractions among exposed municipality-months (AFE). Sensitivity analyses evaluated alternative PM2.5 thresholds (15 and 35 g/m3), co-pollutants, and agricultural expansion. Findings From Jan 1, 2003 to Dec 1, 2023, 1,758,982 TB cases were reported. Of these, 353,319 (20.1%) had at least one high-exposure day (PM2.5 > 25 g/m3) 1-24 months before notification. An additional 14 high-exposure days over the 24-month lag period was associated with an average monthly increase of 2.9% [95% CI: 0.9-4.9%] in TB notification rates. Effects peaked at 13 months (IQR: 11-14) prior to notification. Results showed a dose-response relationship across PM2.5 thresholds and were robust to controlling for NO2, O3, and agricultural expansion. Overall, wildfire-related PM2.5 exposure accounted for 2.1% [0.7-3.5%] of TB notifications in exposed municipality-months, corresponding to 7,802 [2,612-12,544] attributable cases. The AFE reached 10.7% [7.1-14.0%] in Pantanal and 7.3% [6.1-8.5%] in Amazonia, areas most impacted by wildfires. Interpretation Wildfire-related PM2.5 exposure may represent an increasingly important and modifiable risk factor for TB. As wildfire activity increases across many regions of the world, these findings highlight the need for integrating air quality into climate adaptation and TB control strategies.
]]></description>
<dc:creator><![CDATA[ Pham, T. M., Mendonca, T., Zhang, Y., Mallia, D., Croda, J., Cohen, T., Andrews, J. R., Requia, W., Walter, K. S. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26356762</dc:identifier>
<dc:title><![CDATA[Impact of wildfire-related fine particulate matter on tuberculosis notifications in Brazil: a nationwide panel study, 2003-2023]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357043v1?rss=1">
<title>
<![CDATA[
HABITAT: Evolution of a Cloud-Based, Mesh-Enabled Research Data Ecosystem at an Academic Medical Center 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357043v1?rss=1
</link>
<description><![CDATA[
Academic medical centers face growing demand for clinical data access that traditional informatics infrastructure cannot support at scale. We describe HABITAT, a governed, tiered research data ecosystem at the University of Missouri integrating internal and external sources, including unstructured clinical data, into a layered architecture supporting PCORnet and OMOP common data models. A three-tier model provides self-service feasibility tools, secure cloud analytics, and curated honest broker services under a Five Safes governance framework. From mid- 2022 through February 2026, HABITAT received 1,150 requests with 689 fulfilled and supported 29 externally funded projects. Median fulfillment for internal data requests improved from 30 to 20 days, and an early survey captured 54 scholarly outputs, including peer-reviewed publications in high-impact journals. HABITAT supported coursework to multi-site research without proportional staff increases, while cost r
]]></description>
<dc:creator><![CDATA[ Jampani, Y., McClay, J., Rana, M. K. Z., Mandhadi, V., Mcmahon, T., Niu, X., Islam, M. S., Hossain, S. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357043</dc:identifier>
<dc:title><![CDATA[HABITAT: Evolution of a Cloud-Based, Mesh-Enabled Research Data Ecosystem at an Academic Medical Center]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26357095v1?rss=1">
<title>
<![CDATA[
Integrative analysis of cfDNA features from ultra-low coverage whole genome sequencing enables robust detection of ovarian cancer 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26357095v1?rss=1
</link>
<description><![CDATA[
Background: Despite advances in circulating tumor DNA analysis, reliable detection of oncological disease from ultra-low coverage whole genome sequencing (ulcWGS) remains challenging, particularly at low tumor fractions. This study leverages cell-free DNA (cfDNA) characteristics to develop and evaluate a robust, integrative binary predictive model  for ovarian cancer (OC) status screening. OC represents a growing global burden and is often diagnosed at advanced stages due to the lack of specific early symptoms and effective screening strategies, highlighting the need for sensitive and broadly applicable early detection approaches.Methods and Findings: We analyzed plasma cfDNA from OC patients (N = 85) and cancer-free controls (N = 41) using ulcWGS (~1x). Participation in the study was voluntary, and all participants provided written informed consent before any study-related procedures under study approval No. 16119-8/2022/EUIG. Within an integrated workflow combining standardized laboratory processing, bioinformatic pipelines, and machine learning (ML), we extracted 21 features capturing copy number variations (CNVs) and fragmentomic characteristics to identify complementary signatures distinguishing OC from controls. Predictive models were developed using XGBoost with hyperparameter optimization and evaluated on an independent test set (n = 25% of the cohort). A dual-threshold classification strategy was applied to define an uncertainty zone and optimize screening performance.CNV-derived and fragmentomic features assessed in exploratory analysis on the training-validation set showed moderate discriminative power (AUC 0.569 - 0.946) but substantial overlap between groups. On the test set, the CNV-only model achieved an AUC of 0.855 (sensitivity 85%, specificity 50%), while the fragmentomics-only model reached an AUC of 0.8825 (sensitivity 95%, specificity 30%). Both feature domains captured complementary aspects of tumor-derived cfDNA, with fragmentomics favoring sensitivity and CNV-derived metrics improving specificity. Integration of both feature classes improved performance, yielding an AUC of 0.900, sensitivity of 85.00%, and specificity of 90.00%. SHAP analysis confirmed contributions from both feature types without a single dominant predictor.Conclusions: We present an integrative cfDNA framework for OC detection based on ulcWGS that combines CNV and fragmentomic signals to improve diagnostic performance over single-feature approaches. By enabling robust detection of tumor-associated patterns at ultra-low sequencing depth, this approach demonstrates that meaningful cancer discrimination can be achieved without reliance on deep sequencing. This highlights the potential of cost-effective and scalable liquid biopsy strategies for population-level cancer screening their integration into personalized and preventive oncology.  Keywords: Liquid biopsy, ovarian cancer, ultra-low coverage whole genome sequencing, cell-free DNA, cell-free tumor DNA, cancer detection, copy number variations, insert size, fragmentomics, machine learning
]]></description>
<dc:creator><![CDATA[ Hanzlikova, Z., Styk, J., Pös, O., Biro, O., Bokorova, S., Lukyova, L., Sitarcik, J., Sladecek, T., Krampl, W., Meszaros, A., Hunyadi, P., Mate, S., Egeto, A., Rigo, J., Sedlackova, T., Radvanszky, J., Budis, J., Szemes, T. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26357095</dc:identifier>
<dc:title><![CDATA[Integrative analysis of cfDNA features from ultra-low coverage whole genome sequencing enables robust detection of ovarian cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26356192v1?rss=1">
<title>
<![CDATA[
Concordance in pregnancy planning, preconception health behaviours and health information-seeking of pregnant couples: a cross-sectional study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26356192v1?rss=1
</link>
<description><![CDATA[
Introduction:Relational dynamics between partners within a couple planning pregnancy are critical to their preconception health behaviour change and are largely underexamined. Given the need for both reproductive partners to engage in beneficial preconception health behaviours and the influence couples have on each others behaviour, this study examines the concordance between pregnancy planning and preconception health behaviours and health information-seeking within reproductive partner dyads. Methods:A retrospective observational study was undertaken utilizing data from two online cross-sectional 80-item surveys administered simultaneously between December 2020 and September 2021. Eligible study participants were females or birthing people aged 18-49 living in Australia during any stage of pregnancy, and reproductive partners of those that met these criteria. The survey items covered sociodemographic characteristics, level of pregnancy planning, preconception health behaviours, health information seeking, and health history. Cohens kappa (K) (categorical variables) and interclass correlation coefficients (ICC) (continuous variables) were used to identify agreement within the couples. Results:Eighty matched dyads of pregnant females and non-pregnant partners were included. Concordance in pregnancy planning was fair (K=0.27) and was primarily seen in couples where both partners reported the pregnancy as planned (42.5%) or ambivalent (18.8%). Couples had very low similarity (ICC:0.22) in weekday alcohol consumption 3 months preconception (pregnant females: 1.2 standard drinks per day (SD1.7); non-pregnant partners: 2.5/day (SD3.5)). Approximately one quarter (26.3%) of couples reported similarities in partners attempting and succeeding in preconception health information-seeking 12 months before pregnancy. There was greater concordance in not discussing preconception health topics with GPs, including topics explicitly covered within clinical guidelines. Conclusion:There is notable discordance in couples preparation for pregnancy in many behaviours relevant to positive pregnancy outcomes, and in their health service engagement and experience. There is a clear need to provide care to both reproductive partners to ensure the best possible outcome for the future generations.
]]></description>
<dc:creator><![CDATA[ Carter, T., Schoenaker, D., Marron, G., Colas, L., Steel, A. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26356192</dc:identifier>
<dc:title><![CDATA[Concordance in pregnancy planning, preconception health behaviours and health information-seeking of pregnant couples: a cross-sectional study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26357097v1?rss=1">
<title>
<![CDATA[
Maternal and perinatal outcomes among pregnant women with sickle cell disease in Uganda: a prospective cohort study. 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26357097v1?rss=1
</link>
<description><![CDATA[
Background: Pregnancy in women with sickle cell disease (SCD) is associated with substantial maternal and perinatal risk, but prospective data from Uganda remain limited. We described the clinical profile, maternal complications, and fetal and neonatal outcomes among pregnant women with confirmed SCD receiving tertiary-level care in Uganda. Methods: We conducted a hospital-based prospective cohort study of 159 pregnant women with confirmed HbSS at Kawempe National Referral Hospital and Mbale Regional Referral Hospital, Uganda, between October 2024 and March 2026. Participants were recruited consecutively during antenatal care or at admission for delivery and followed until maternal discharge. Outcomes were summarized descriptively using explicit denominators. Maternal complications were reported at woman level, while fetal and neonatal outcomes were reported at fetus/newborn level to account for multiple gestations. Secondary regression analyses were treated as exploratory. Results: The mean maternal age was 24.3 years (SD 4.7), and 82/159 women (51.6%) were referred in labor or on admission rather than being known from the study-site antenatal clinics. At baseline, median hemoglobin was 7.5 g/dL (IQR 6.4-8.75), and 118/132 women (89.4%) had hemoglobin below 10 g/dL. The most frequent maternal complications were anemia (93/159, 58.5%), vaso-occlusive crisis (87/159, 54.7%), acute chest syndrome (31/159, 19.5%), recurrent infections (27/159, 17.0%), postpartum hemorrhage (21/159, 13.2%), and preeclampsia (17/159, 10.7%). Maternal death occurred in 15/159 women (9.4%). Among women with recorded mode of delivery, 107/137 (78.1%) delivered by caesarean section. The 159 women contributed 166 fetal outcomes, including seven twin pregnancies. Of these, 22/166 (13.3%) were abortions. Among 144 fetal/newborn outcomes after exclusion of abortions, 119/144 (82.6%) were live births and 25/144 (17.4%) were stillbirths. Early neonatal death occurred in 12/119 live births (10.1%). Low birthweight occurred in 76/117 newborns with recorded birthweight (65.0%), and NICU admission was recorded in 83/118 newborns with recorded admission status (70.3%). Conclusion: Pregnancy among women with SCD receiving tertiary referral care in Uganda was characterized by high maternal morbidity, substantial maternal mortality, and poor fetal and neonatal outcomes. The findings support early identification and referral, structured multidisciplinary antenatal care, reliable transfusion readiness, rapid escalation for acute chest syndrome, preeclampsia and infection, and close coordination between obstetric and neonatal services.
]]></description>
<dc:creator><![CDATA[ Akello, J., Kiguli, S., Ndeezi, G., Sekikubo, M., Mwaka, S., Munabi, I., Namazzi, R., Mununbe, D., Mukunya, D., Pebolo, P., Mugabe, K., Rujumba, J., Nakimuli, A. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26357097</dc:identifier>
<dc:title><![CDATA[Maternal and perinatal outcomes among pregnant women with sickle cell disease in Uganda: a prospective cohort study.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26356954v1?rss=1">
<title>
<![CDATA[
Vision-Based Automated Severity Rating of REM Sleep Behavior Disorder: From Heuristic Features to Foundation Models 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26356954v1?rss=1
</link>
<description><![CDATA[
Automated severity rating of rapid eye movement (REM) sleep behavior disorder (RBD) movements would enable multi-night monitoring to detect potentially injurious behaviors and provide objective endpoints for clinical trials. We compared a heuristic classifier using optical flow-derived features against V-JEPA2, a self-supervised video foundation model, for clip-level severity classification (3329 mild versus 284 moderate-to-severe) of in-laboratory video-polysomnography infrared recordings in 86 isolated RBD patients. V-JEPA2 with checkpoint fine-tuning and maximum optical flow-based frame sampling achieved the best performance across both evaluation conditions -- Macro F1 of 0.76 and 93% accuracy in the clip-level split, and 0.68 and 85% in the patient-level split -- outperforming heuristic and domain-specific pretrained models. Clip duration was the dominant heuristic predictor. Whole-night severity scores preserved patient-level ordering despite systematic overestimation, with V-JEPA2 achieving a mean absolute error of 25% versus 52% for the heuristic classifier. These findings establish a foundation for objective, home-deployable monitoring of RBD severity.
]]></description>
<dc:creator><![CDATA[ Hwang, J., van Pesch, N., Raval, B., Abdelfattah, M., Gafsi, A., Bertolaso, A., Ryu, K. H., Marwaha, S., Sum-Ping, O., Cesari, M., Stefani, A., Brink-Kjaer, A., Mignot, E., Alahi, A., During, E. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26356954</dc:identifier>
<dc:title><![CDATA[Vision-Based Automated Severity Rating of REM Sleep Behavior Disorder: From Heuristic Features to Foundation Models]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357034v1?rss=1">
<title>
<![CDATA[
LRRK2 in Focus: A Global Browser Linking Genetic Diversity to Functional Effects 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357034v1?rss=1
</link>
<description><![CDATA[
Background: LRRK2 variants are major contributors to Parkinsons disease (PD). Many pathogenic variants increase kinase activity, underscoring the value of functional assays in nominating therapeutic targets and kinase inhibitors as potential disease-modifying therapies. Objective: To develop an interactive resource that provides functional context and ancestry-specific variant frequencies. Methods: Genotyping and short-read sequencing data were analyzed for 101,678 individuals (61,709 PD, 39,969 controls) from the Global Parkinsons Genetics Program (GP2) and integrated with clinical and in-vitro biochemical kinase activity information. Results: The LRRK2 Browser (http://gp2.org/lrrk2browser) displays ancestry-specific genetic data for 19,596 LRRK2 variants (968 exonic, 14 disease-associated) across 11 populations, and functional data for 171 variants. Clinical annotations include age, age at onset, and family history of PD. Discussion: The publicly available LRRK2 Browser represents an open-access, multi-ancestry resource to support LRRK2 variant interpretation. It aims to enhance the translational potential of genetic and functional data for precision medicine and the implementation of gene-targeted therapies in diverse populations.
]]></description>
<dc:creator><![CDATA[ Grant, S. M., van Midden, V., Fernandez-Toledo, E., Cham, M., Sammler, E., Alessi, D., The Global Parkinson's Genetics Program,, Morris, H., Blauwendraat, C., Singleton, A. B., Lange, L. M. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357034</dc:identifier>
<dc:title><![CDATA[LRRK2 in Focus: A Global Browser Linking Genetic Diversity to Functional Effects]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357080v1?rss=1">
<title>
<![CDATA[
Knowledge Base and Emerging Frontiers in Post-Tuberculosis Lung Disease Research (2015-2025): A Bibliometric Analysis Based on the Web of Science 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357080v1?rss=1
</link>
<description><![CDATA[
Background: Post-tuberculosis lung disease (PTLD) constitutes a substantial global public health burden, yet its overall research landscape has not been systematically quantified. This bibliometric study characterizes global research trends and the knowledge architecture of PTLD publications issued between 2015 and 2025. Methods: We retrieved PTLD-related literature from the Web of Science Core Collection using search terms including "post-tuberculosis lung disease" and "tuberculosis sequelae". Only English original articles were retained, yielding a final dataset of 353 publications. We adopted VOSviewer, CiteSpace and the Bibliometrix R package to visualize annual publication outputs, cross-country and institutional collaborations, author co-authorship networks, keyword co-occurrence patterns, and citation burst dynamics. Results: Annual publications rose from 13 in 2015 to 67 in 2025, with 71.4% of all papers published from 2021 to 2025. The five most productive nations were the United States (72 papers), India (61), China (51), the United Kingdom (49), and South Africa (38). The US and UK occupied core hub positions in international collaboration networks. Leading institutions included Stellenbosch University (20 articles), the University of Cape Town (14), and the University of Liverpool/Liverpool School of Tropical Medicine (10). Keyword co-occurrence clustering identified eight thematic groups, with dominant hotspots covering post-tuberculosis bronchiectasis, pulmonary function impairment, chronic pulmonary aspergillosis (CPA), and quality of life. The keywords with the strongest recent citation bursts were "post-tuberculosis lung disease" (strength = 3.79), "prevalence" (3.70), and "quality of life" (2.51). Research frontiers extending to 2025 center on standardized PTLD conceptual framing, pulmonary rehabilitation, and long-term clinical outcome assessment. Conclusions: PTLD research has shifted from merely describing structural lung damage toward standardized disease definitions, functional pulmonary testing, complication management, and patient quality-of-life improvement. Future research priorities should include prospective multicenter cohort studies, individualized pulmonary rehabilitation programs, and host-directed therapies to mitigate the global burden of chronic PTLD.
]]></description>
<dc:creator><![CDATA[ Zhu, T., Feng, Y., Dai, Y., Yu, J., Zhang, Z., Liu, Z. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357080</dc:identifier>
<dc:title><![CDATA[Knowledge Base and Emerging Frontiers in Post-Tuberculosis Lung Disease Research (2015-2025): A Bibliometric Analysis Based on the Web of Science]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26357105v1?rss=1">
<title>
<![CDATA[
Combined triglyceride-glucose and frailty index (TyGFI) and risk of endometrial cancer in U.S. women aged >=45: NHANES 2011-2018 analysis integrating data engineering and machine learning with logistic modeling 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26357105v1?rss=1
</link>
<description><![CDATA[
Endometrial cancer (EC) incidence is closely linked to metabolic and hormonal factors. The TyGFI, a composite indicator integrating the triglyceride-glucose index and frailty index, may capture combined risk dimensions relevant to EC etiology and prediction. This study aimed to evaluate the association between TyGFI and EC prevalence among U.S. women aged 45 years and older, and to explore its predictive utility using machine-learning approaches. Data were drawn from the National Health and Nutrition Examination Survey 2011-2018 cycles. The exposure was TyGFI, and the outcome was EC status ascertained from self-reported cancer history and standardized questionnaires. From an initial 39,156 participants, we excluded males, individuals aged under 45 years, those missing TyGFI components or EC data, and extreme TyGFI values, yielding a final cohort of 2,837 women. We performed exploratory feature selection and built six predictive models using machine-learning algorithms to identify key predictors and evaluate TyGFI's contribution to model performance. Survey-weighted multivariable logistic regression estimated the association between TyGFI and EC prevalence with sequential adjustment for covariates. In a weighted sample representing 30,489,082 U.S. women aged 45 years and older, higher TyGFI was significantly associated with EC prevalence. After full adjustment, each unit increase in TyGFI corresponded to a 57% increase in the odds of EC (odds ratio 1.570; 95% confidence interval 1.033-2.370; p = 0.0322), with a significant dose-response trend across quartiles (p for trend = 0.0257). Among six machine-learning models, CatBoost achieved the highest predictive performance, with an area under the curve of 0.999. SHAP analysis identified TyGFI as the most influential predictor, followed by age and serum albumin. In this nationally representative sample of middle-aged and older U.S. women, TyGFI was significantly associated with EC prevalence and emerged as the dominant predictor in machine-learning models. These findings suggest that TyGFI may enhance risk stratification for EC beyond established reproductive and metabolic factors, though prospective studies are warranted to validate its clinical utility.
]]></description>
<dc:creator><![CDATA[ Zhou, Y., Ma, J., Zhang, Y. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26357105</dc:identifier>
<dc:title><![CDATA[Combined triglyceride-glucose and frailty index (TyGFI) and risk of endometrial cancer in U.S. women aged >=45: NHANES 2011-2018 analysis integrating data engineering and machine learning with logistic modeling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26357096v1?rss=1">
<title>
<![CDATA[
Identifying Active Paragonimiasis in Rural Nagaland in Northeastern India- a Community-Based Cross-Sectional Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26357096v1?rss=1
</link>
<description><![CDATA[
Background Paragonimiasis is a neglected tropical disease (NTD) and of significant public health concern in northeastern India where it is frequently misdiagnosed as pulmonary tuberculosis. Transmission occurs through consumption of raw or undercooked freshwater crustaceans, a widespread dietary practice in this region. Accurate diagnosis will ensure cheap, effective treatment with praziquantel and avoid unnecessary prolonged tuberculosis therapy. This study determines the prevalence, specific risk factors for infection, and showcases a clinical scoring model to screen for active paragonimiasis in endemic areas. Methodology/Principal Findings A community-based cross-sectional survey was conducted in Medziphema block, Nagaland, in northeastern India screening 2,942 residents aged over 10 years. Participants reporting chronic cough ([&ge;]2 weeks) provided sputum and serum samples (93,3.16%). Sputum examination was screened for Paragonimus ova and acid-fast bacilli, and serum samples were tested for IgG antibodies against Paragonimus heterotremus using anti-Extra Secretory antigen by ELISA (positive case defined as titre [&ge;]0.5 IU). IgG-confirmed paragonimiasis was detected in 30 individuals, yielding a population prevalence of 1.02% (30/2942) and 32.3% (30/93) amongst symptomatic participants. Sputum microscopy demonstrated limited sensitivity (3.3%), detecting cysts in only one confirmed case. Tuberculosis co-infection was documented in 6.7% of sero-positive cases.  Multivariable regression identified significant associations with increasing age (adjusted (aOR) 1.04) previous tuberculosis history (aOR 4.62), monthly snail consumption frequency (aOR 1.05), ever smoking (aOR 3.51), and education beyond middle school (aOR 2.93). Haemoptysis (aOR 9.86) was the strongest symptomatic predictor. Clinical scoring models were developed, with haemoptysis consistently emerging as the most robust predictor across all models. Conclusions/Significance Pulmonary paragonimiasis constitutes a prevalent yet under-recognised condition in several southeast-Asian communities, necessitating systematic screening as a differential diagnosis for pulmonary tuberculosis. The clinical scoring model facilitates early case identification in resource-constrained settings. Public health interventions must address dietary practices, particularly consumption of raw or undercooked freshwater crustaceans, to interrupt transmission.
]]></description>
<dc:creator><![CDATA[ Ramesh, R. M., Panmei, K., Lohe, A., Deborah, A. A., Humtsoe, T., Khamo, V., Ajjampur, S. S. R., Joseph, A. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26357096</dc:identifier>
<dc:title><![CDATA[Identifying Active Paragonimiasis in Rural Nagaland in Northeastern India- a Community-Based Cross-Sectional Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26357125v1?rss=1">
<title>
<![CDATA[
Visible Immigration Enforcement Arrests and Mental Health Among Hispanic Adults in the United States 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26357125v1?rss=1
</link>
<description><![CDATA[
Objectives: To assess whether higher state-level community-based U.S. Immigration and Customs Enforcement (ICE) arrest rates are associated with adverse mental health outcomes among Hispanic and non-Hispanic adults in the United States. Design: Retrospective analysis using individual-level data from the 2023 and 2024 Behavioral Risk Factor Surveillance System (BRFSS) linked to monthly state-level ICE arrest records from the Deportation Data Project. Two-way fixed effects models assessed associations between mental health outcomes and ICE arrests, net of secular trends, state-specific time invariant factors, and individual covariates. Setting/participants: The sample included 534,099 US adults aged 18 years or older residing in all 50 states and the District of Columbia surveyed between September 2023 and December 2024. Analyses exploited within-state month-to-month variation in enforcement intensity with state and year-month fixed effects. Outcome measures: Number of poor mental health days in the past 30 days; any poor mental health days (binary); mental health status (3-level categorical); frequent mental distress ([&ge;]14 poor mental health days); and a composite indicator combining depressive disorder diagnosis with frequent mental distress. Results: Among 534,099 respondents (approximately 10% Hispanic), higher ICE arrest rates were significantly associated with worse mental health among Hispanic adults, including 0.19 additional poor mental health days per month (p < 0.05), a 2.2% higher likelihood of reporting any poor mental health days (p < 0.01), and a 2.4% increase in composite mental health problems (p < 0.01). Associations were concentrated among Hispanic women and those with a high school diploma or less. Among non-Hispanic adults, estimates were small and precisely centered around zero across outcomes. Similar findings obtained in difference-in-differences event study models, models including lagged exposures, and models with leave-one-out state exclusions. Conclusion: Higher community-based immigration enforcement was associated with worse mental health outcomes among Hispanic adults but not among non-Hispanic adults. Contemporary enforcement strategies may have broader psychological spillover effects within Hispanic communities, and mental health may be an underrecognized social cost of interior immigration enforcement.
]]></description>
<dc:creator><![CDATA[ Aslim, E., Tekin, D., Venkataramani, A. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26357125</dc:identifier>
<dc:title><![CDATA[Visible Immigration Enforcement Arrests and Mental Health Among Hispanic Adults in the United States]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357063v1?rss=1">
<title>
<![CDATA[
The VOICE-DEP study protocol: multimodal analysis of voice and discourse during medical interviews to support diagnosis and longitudinal monitoring of major depressive disorder 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357063v1?rss=1
</link>
<description><![CDATA[
Background: Major depressive disorder is a severe, recurrent and disabling condition. Although diagnosis and clinical monitoring are based on medical interviews and validated rating scales, speech and discourse analysis may provide complementary digital biomarkers reflecting depressive severity and clinical evolution. However, current evidence remains limited by methodological heterogeneity, predominantly cross-sectional designs, limited longitudinal data and underrepresentation of non-English-speaking clinical populations. Objective: The aim of the VOICE-DEP study is to develop and formalize a standardized, reproducible and clinically grounded protocol for the multimodal analysis of voice and discourse during medical interviews as a tool to support the diagnosis of depressive disorder and to assess whether speech-derived biomarkers change over time in parallel with clinical severity measures. Methods: VOICE-DEP is an observational, prospective, longitudinal pilot study of patients with major depressive disorder with a healthy control group, conducted in a hospital-based clinical setting in Spain. The study will include 25 adult patients with moderate or severe unipolar depression, with or without psychotic symptoms, and 50 healthy controls without a personal history of psychiatric disorders. Patients will be assessed at five time points: baseline (V0) and four monthly follow-up visits at 30, 60, 90 and 120 days. Healthy controls will be assessed once at baseline. The planned dataset comprises 175 voice recordings: 125 from patients and 50 from controls. At each assessment, the Montgomery-Asberg Depression Rating Scale related part of the medical interview, lasting approximately 10-30 minutes and including an initial free-speech segment, will be recorded using a standardized audio protocol. Acoustic, paralinguistic and linguistic features will be extracted and analyzed in relation to clinician-rated severity measures and self-reported symptoms. Ethics: This protocol has been reviewed and approved by the local Research Ethics Committee, which complies with the international standards of GCP CPMP/ICH/135/95 (Comunidad Foral de Navarra Research Ethics Committee; reference code: 2026.110). Written informed consent will be obtained from all participants before any study procedure. Voice recordings and clinical data will be pseudonymized, stored securely and processed in accordance with applicable Spanish and European data protection regulations. Expected outcomes: This protocol is expected to generate a clinically grounded Spanish-language longitudinal speech corpus and a transparent analytical framework for evaluating voice- and discourse-derived biomarkers as complementary tools for depression assessment and monitoring
]]></description>
<dc:creator><![CDATA[ Zabalza-Zudaire, M., Sayar-Beristain, O., Fructos, P., Nunez, F. E., Carpio, F. F., Garcia, E., Ortiz, A., Ortuno, F., Aldaz, A., Molero, P. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357063</dc:identifier>
<dc:title><![CDATA[The VOICE-DEP study protocol: multimodal analysis of voice and discourse during medical interviews to support diagnosis and longitudinal monitoring of major depressive disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357066v1?rss=1">
<title>
<![CDATA[
Group interpersonal psychotherapy for depression in Uganda: intervention effects and the influence of social desirability bias in a pilot cluster randomized trial 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357066v1?rss=1
</link>
<description><![CDATA[
Introduction: Group interpersonal psychotherapy (IPT-G) can expand access to depression care, but assessment conditions may influence outcomes. This pilot cluster-randomized trial was designed to refine outcome-measurement procedures and generate preliminary effect estimates to inform a larger trial. We evaluated a six-week model, examining associations between follow-up assessment conditions and depressive symptoms. Methods: In Mayuge, Uganda, female participants aged [&ge;]13 years with Patient Health Questionnaire-9 (PHQ-9) scores [&ge;]10 were randomized by village to IPT-G or enhanced treatment as usual. Primary outcome was the PHQ-9 score. Assessments occurred at baseline, two weeks and three months post-treatment. During early two-week follow-up, therapy facilitators remained visible near interview locations while mobilizing participants; thereafter, they left before subsequent interviews. At three months, interviews were conducted independently and participants were randomly assigned to receive a prompt emphasizing confidentiality, accurate reporting and that incentives were not contingent on responses. We examined associations between these two conditions and PHQ-9 scores. Results: Of 292 randomized participants, 263 provided three-month data. Mean PHQ-9 scores were lower in intervention than control participants at two weeks (1.73 versus 15.14; mean difference [MD] -13.41, 95% confidence interval [CI] -16.10 to -10.71) and three months (3.19 versus 10.97; MD -7.78, 95% CI -9.66 to -5.90; both p<0.001). Among intervention participants, prior assessment without facilitators and receipt of the confidentiality and honest-reporting prompt were jointly associated with 4.41-point higher PHQ-9 scores versus the reference condition (95% CI 2.37 to 6.45; p<0.001). In exploratory sensitivity analysis, an intervention subgroup exposed to both conditions had lower three-month PHQ-9 scores than controls (MD -5.19, 95% CI -7.39 to -2.99; p<0.001). Conclusions: Six-week IPT-G was associated with significant symptom reductions, but follow-up procedures influenced the apparent benefit, highlighting the need for independent outcome assessment in community-delivered psychological intervention trials. Trial registration: Pan African Clinical Trials Registry, PACTR202606549854263; retrospectively registered.
]]></description>
<dc:creator><![CDATA[ Atuhumuza, E., Ssanyu, J. N., Fraker, A., Nakalungi, S., Ndeezi, M., Mujune, V., Oloya, C., Naisanga, M., McManus, J., Huang, C. H., Kasujja, R. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357066</dc:identifier>
<dc:title><![CDATA[Group interpersonal psychotherapy for depression in Uganda: intervention effects and the influence of social desirability bias in a pilot cluster randomized trial]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26356561v1?rss=1">
<title>
<![CDATA[
Microbial and immune determinants of disease severity and death in pediatric pneumonia. 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26356561v1?rss=1
</link>
<description><![CDATA[
Pneumonia is a leading cause of death globally and disproportionately affects children in lower- and middle-income countries. To explore microbial and immune correlates of disease and death, we performed metagenomic sequencing of upper respiratory tract (URT) microbiome in 309 children in Mali with pneumonia and 150 age- and season- and site-matched controls. We show that the URT microbiome matures throughout early life and is influenced by breastfeeding. URT microbiome maturation was disrupted during pneumonia resulting in loss of commensal species and expansion of pathobionts, which was linked to disease severity and death. Analysis of serum antibody levels revealed that low levels of passively acquired antibody from mothers, deficient antibody responses to RSV, and persistent autoantibody to cytokines were associated with pneumonia mortality in an age-dependent manner. These findings underscore the complex nature of pneumonia and identify microbial and immune factors for risk stratification and therapeutic interventions in pediatric pneumonia.
]]></description>
<dc:creator><![CDATA[ Hanze Villavicencio, K., Tanes, C., Malekshahi, C., Cutillo, D., Knoll, M. D., Prosperi, C., Kalaycioglu, M., Harris, M., Utz, P. J., Mattei, L., Beiting, D. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26356561</dc:identifier>
<dc:title><![CDATA[Microbial and immune determinants of disease severity and death in pediatric pneumonia.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357053v1?rss=1">
<title>
<![CDATA[
Single-nucleus transcriptomic analysis of pediatric pancreas reveals cellular heterogeneity and early neoplasia signatures during chronic pancreatitis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357053v1?rss=1
</link>
<description><![CDATA[
Background: Pediatric chronic pancreatitis (CP) carries an elevated lifetime risk of pancreatic ductal adenocarcinoma (PDAC), yet the cellular and molecular mechanisms driving disease progression and early neoplastic transformation remain undefined. Methods: We performed single-nucleus RNA sequencing (snRNA-seq) on pancreatic tissue from 15 pediatric CP individuals and 6 healthy controls (HC). Findings were integrated with peripheral blood flow cytometry immunophenotyping of 8 CP and 7 HC individuals and validated by histopathological assessment. Findings: We identified 15 distinct cell populations and profound cellular remodeling in CP, including a 46% reduction in acinar cells and emergence of inflammatory fibroblasts as the dominant stromal population. Acinar-to-ductal metaplasia (ADM) and pancreatic intraepithelial neoplasia (PanIN) populations bearing early PDAC-associated transcriptional signatures were detected in most CP samples. Cell-cell interaction analysis revealed that 68% of CP-specific ligand-receptor interactions converged on ADM and PanIN populations via ECM-integrin and inflammatory pathways. Peripheral blood flow cytometry demonstrated concordant systemic immune activation, including elevated monocyte CCR2 and CD80, increased CD69 on T cells, and upregulated ROR{gamma}t in regulatory T cells. Interpretation: This atlas defines the cellular landscape and intercellular signaling networks underlying pediatric CP, identifying inflammatory fibroblasts and early neoplastic cell states as central features. These findings provide a molecular foundation for understanding cancer risk in pediatric CP and provide a resource to prioritize studies into potential therapeutic targets and biomarkers. Funding: This work was supported by the Network for Pancreatic Organ donors with Diabetes (nPOD) and The Leona M. & Harry B. Helmsley Charitable Trust.
]]></description>
<dc:creator><![CDATA[ Ahmed, F., Xie, X., Dixit, A., Moreno-Fernandez, M. E., Patel, E. H., Gurria, J., Khoury, K., Christian, P., Bottino, R., Kumaragurubaran, R., Adeleke, D., Wasserfall, C. H., Wang, Y., Abu-El-Haija, M. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357053</dc:identifier>
<dc:title><![CDATA[Single-nucleus transcriptomic analysis of pediatric pancreas reveals cellular heterogeneity and early neoplasia signatures during chronic pancreatitis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26356511v1?rss=1">
<title>
<![CDATA[
Designing infection prevalence and seroprevalence surveys for learning infection dynamics 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26356511v1?rss=1
</link>
<description><![CDATA[
Knowledge of the true number of infections over time is valuable for accurately predicting the future course of an epidemic and planning effective interventions, but the number of cases reported offers only a noisy underestimate of the true number of infections. Disease surveillance strategies based on assessing subsets of the population for current infection (infection prevalence surveys) or antibody presence (seroprevalence surveys) yield crucial information about the number truly infected, but are expensive. To explore impact of survey design considerations--both sample size and sampling frequency--on inference of the number of incident infections over time, we coupled agent-based simulations of respiratory virus epidemics with simulations of infection prevalence and seroprevalence surveys. While returns diminish with increased sample size, we find inference generally improved by increasing survey frequency relative to participants-per-round for any given sample size. After survey rounds reach a sufficient frequency, comparable inference performance may be achieved with either more frequent rounds or more participants per round. Rolling designs with tests conducted each day tend to outperform designs in which testing is divided into discrete rounds. We also show that misspecified assumptions about seroreversion may substantially decrease the quality of inference results.
]]></description>
<dc:creator><![CDATA[ Creswell, R., Golding, N., Ryan, G. E., Eales, O., Price, D. J., McCaw, J. M., Shearer, F. M. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26356511</dc:identifier>
<dc:title><![CDATA[Designing infection prevalence and seroprevalence surveys for learning infection dynamics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26357104v1?rss=1">
<title>
<![CDATA[
Deep Learning based Quantification of Root Exposure in Lower Anterior Teeth using Intraoral camera image 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26357104v1?rss=1
</link>
<description><![CDATA[
This study compared and evaluated two widely used deep learning-based artificial intelligence (AI) models, U-Net++ and YOLOv11, for quantifying tooth and root exposure on intraoral camera images of the mandibular anterior lingual region. Intraoral images of the mandibular anterior lingual region were collected from 291 patients (mean age, 52.8 years) at a university hospital dental clinic with institutional review board approval (YUMC IRB 2021-07-019-002). A total of 266 eligible images (mean, 5.50 teeth per image; 3.70 teeth with root exposure) were annotated. YOLOv11 and U-Net++ were fine-tuned using five-fold cross-validation with data augmentation. Model performance was evaluated on a held-out test set of 40 images using Dice coefficient, Intersection over Union (IoU), accuracy, mean Average Precision at an IoU threshold of 0.5 (mAP50), Lins concordance correlation coefficient (CCC), and intraclass correlation coefficient (ICC). Confidence intervals were estimated using 10,000 bootstrap iterations. For tooth segmentation, U-Net++ demonstrated superior performance, with high accuracy (0.981), Dice coefficient (0.971), and IoU (0.944). In contrast, for root segmentation, YOLOv11 outperformed U-Net++, achieving higher Dice (0.860 vs. 0.746) and IoU (0.762 vs. 0.631). Notably, YOLOv11 showed stronger agreement with the ground truth for quantifying the exposed root ratio (ERR) (CCC, 0.973; ICC, 0.975). These findings suggest that accurate detection of root exposure is important for assessing periodontal tissue loss and that YOLOv11 is a promising model for root exposure quantification in intraoral images. YOLOv11-based quantification of root exposure may serve as a useful adjunctive AI tool for screening and monitoring periodontal conditions and may support individualized treatment planning.
]]></description>
<dc:creator><![CDATA[ Choi, H., Choi, Y.-H., Park, E. Y., Kang, S., Kim, E.-K. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26357104</dc:identifier>
<dc:title><![CDATA[Deep Learning based Quantification of Root Exposure in Lower Anterior Teeth using Intraoral camera image]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357075v1?rss=1">
<title>
<![CDATA[
Complementary and alternative medicine use among patients with tuberculosis at a tertiary hospital in Sierra Leone: A cross-sectional study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357075v1?rss=1
</link>
<description><![CDATA[
Background: Complementary and alternative medicine (CAM) is widely used alongside biomedical treatment in sub-Saharan Africa, yet evidence among patients with tuberculosis (TB) is limited. Concurrent herbal and anti-TB drug use raises concerns about safety, communication, and symptom attribution. We aimed to estimate the prevalence and describe patterns of CAM use, and to explore sociodemographic associations and disclosure practices among adults receiving TB care. Methods: We conducted a cross-sectional study at Connaught Hospital, Freetown, between February and April 2024. Adults ([&ge;]18 years) with microbiologically confirmed TB were consecutively enrolled. Structured interviews assessed CAM use in the past 12 months, modalities, motivations, adverse experiences, and disclosure. Prevalence was estimated using descriptive statistics. Multivariable logistic regression explored sociodemographic associations with CAM use. Results: Among 160 participants (median age 35 years; 68.1% male), 109 (68.1%, 95% CI 60.6-74.8) reported CAM use. Herbal remedies were the most common modality (74.3% of users), particularly ginger (34.9%) and garlic (20.2%). The primary motivation was symptom relief (73.4%). Only 27.6% of CAM users disclosed use to a healthcare provider, most commonly because they reported not being asked (57.5%). In multivariable analysis, only student status was independently associated with lower odds of CAM use (aOR 0.16, 95% CI 0.05-0.56). Conclusions: CAM use was common among adults receiving TB care and was characterized by frequent herbal use and low disclosure. Routine, non-judgmental inquiry about CAM use may improve communication and patient safety during TB treatment.
]]></description>
<dc:creator><![CDATA[ Jalloh, I. P., Sandy, S. F. F., Kanu, M. S., Sankoh, Z., Bah, F. B., Kanu, A., Barrie, A., Jalloh, F., Smalle, I. O., Abiri, O. T., Lakoh, S., Jalloh, M. B., Baldeh, M., Njai, A. U., Bah, A. K. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357075</dc:identifier>
<dc:title><![CDATA[Complementary and alternative medicine use among patients with tuberculosis at a tertiary hospital in Sierra Leone: A cross-sectional study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357006v1?rss=1">
<title>
<![CDATA[
Epidemiological and Programmatic Insights into Progress toward Ending AIDS by 2030: Lessons from Viet Nams HIV Response 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357006v1?rss=1
</link>
<description><![CDATA[
Introduction Viet Nam has achieved one of the fastest declines in new HIV infections in the WHO Western Pacific Region. In 2020, the Government launched the National Strategy to End the AIDS Epidemic by 2030. At its midpoint in 2025, a national epidemiological and programmatic review was undertaken to assess the countrys progress and remaining challenges. Methods We conducted a review of the national HIV surveillance and programme data and the Joint United Nations Programme on HIV/AIDS database, focusing on four components: disease burden, prevention, testing, and treatment programmes. Results Estimated annual new HIV infections among adults declined from 14,000 (2010) to 6,117 (2024), a 57% reduction, while the number of PLHIV stabilised at 267,455 in 2024. The epidemic has shifted from being mainly among people who inject drugs (PWID) in the 1990s and early 2000s to being increasingly concentrated among men who have sex with men (MSM) and transgender people (TG), who accounted for 58% of new infections in 2024. In 2024, 88% of people living with HIV (PLHIV) knew their status, 79% of those diagnosed received antiretroviral therapy (ART), and 96% of people on ART achieved viral suppression. Harm reduction outcomes were strong, with opioid substitution therapy (OST) coverage around 40% since 2020 and safe injecting practices among PWID above 90% over the last ten years. The pre-exposure prophylaxis programme expanded rapidly in recent years, reaching 17.4% of the MSM. HIV testing volume was 3.4 million in 2024, with an increasing number of confirmatory testing laboratories. HIV status awareness in 2024 was below the 80% national target for sex workers (59.0%), PWID (62.5%), and MSM (79.2%), but exceeded the target for TG (94.1%). The high rate of viral load suppression indicates strong adherence and reflects the overall quality of treatment services. Conclusions Viet Nams progress reflects two decades of sustained harm reduction among people who inject drugs, early adoption of community-led and decentralised HIV testing innovations, rapid scale-up of PrEP, and consistently high viral suppression among people on ART. These combined system and community-based approaches offer transferable lessons for other low- and middle-income countries.
]]></description>
<dc:creator><![CDATA[ Manh, P. D., Otani, M., Nguyen, V., Huong, P. T. T., Duc, B. H., Morishita, F., Tam, N. T. M., Linh, D. T. T., Nhan, D. T., Yadav, R. P. H., Izumi, K. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357006</dc:identifier>
<dc:title><![CDATA[Epidemiological and Programmatic Insights into Progress toward Ending AIDS by 2030: Lessons from Viet Nams HIV Response]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26356352v1?rss=1">
<title>
<![CDATA[
Selection of Mutations in HIV-1 Nucleocapsid and Integrase in Individuals Living with HIV Experiencing Virologic Failure After Initiating or Switching to Tenofovir-Lamivudine-Dolutegravir 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26356352v1?rss=1
</link>
<description><![CDATA[
Background: Tenofovir-lamivudine-dolutegravir (TLD) is an effective, single-tablet ART regimen but the causes of virologic failure that can occur despite adherence to TLD are incompletely understood, especially when resistance mutations in integrase (IN) are absent. Noncanonical resistance mutations in nucleocapsid (NC) have been selected in cell culture and are associated with decreased dolutegravir (DTG) susceptibility in vitro. Samples from the ACTG A5381/Hakim study were examined to assess the potential contribution of NC mutations to virologic failure on TLD. Methods: A5381/Hakim was an observational cohort study that enrolled individuals with HIV-1 RNA >1000 copies/mL when initiating TLD as first line ART or switching from failing non-nucleoside reverse transcriptase inhibitor (NNRTI)-based or protease inhibitor (PI)-based ART. Whole HIV RNA genome next generation sequencing was performed on paired plasma samples from study entry and confirmed virologic failure in 56 participants receiving TLD for [&ge;] six months. Mutations relative to the HIV-1HXB2 reference genome were identified with DeepChek(R) software using a mutation reporting threshold of five percent mixed-base frequency. Canonical drug resistance mutations (DRMs) were identified within the DeepChek(R) software using the Stanford HIVdb v9.8 algorithm. Site-directed NC and IN mutants were tested for susceptibility to DTG, raltegravir and cabotegravir in the TZM-bl HIV-1 indicator cell line and evaluated for infectivity and replication in multi-round assays. Results: Mutations in NC that emerged between TLD initiation and virologic failure were identified in 11 of 56 (20%) participants. Of these 11, three participants also had IN mutations at virologic failure but not at study entry, suggesting dual selection. Selected mutations in the NC zinc-finger domain included V13I, K20R, E21V, N27I/S, A30T, K34R, K38R, K41G/R/N, Q45R and/or M46I, alone or in combination with other NC and/or IN mutations. Specific NC mutations (K20R, N27I, A30T, K41N, M46I) conferred a significant decrease in DTG susceptibility. The combination of certain NC with IN mutations (e.g. NC N27I and IN R263K) conferred greater reduction in susceptibility to DTG in vitro than either mutation alone. Conclusions: This work provides the first clinical evidence of NC mutation selection in individuals on failing TLD ART and shows that NC mutations, combined with IN mutations, can further decrease susceptibility to DTG. Our findings support additional investigations of the contributions of mutations outside of IN to virologic failure of integrase inhibitor-containing ART regimens.
]]></description>
<dc:creator><![CDATA[ Penrose, K. J., Hikichi, Y., Sethi, R., Goetz, B. J., Siffert, L. O., Valiyaparmbil, S. A., Wallis, C. L., McCarthy, C., Wooley, E., Chandran, U. R., Kityo, C. M., Flexner, C., Hughes, M. D., Koenig, S. P., Freed, E. O., Mellors, J. W., Parikh, U. M., ACTG A5381/Hakim Study Team ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26356352</dc:identifier>
<dc:title><![CDATA[Selection of Mutations in HIV-1 Nucleocapsid and Integrase in Individuals Living with HIV Experiencing Virologic Failure After Initiating or Switching to Tenofovir-Lamivudine-Dolutegravir]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26357101v1?rss=1">
<title>
<![CDATA[
Atypical energy-related symptoms define biologically distinct subtypes of major depressive disorder 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26357101v1?rss=1
</link>
<description><![CDATA[
Major depressive disorder (MDD) is a complex psychiatric disorder, characterized by a range of mood, cognitive, and neurovegetative symptoms. Current diagnostic criteria treat opposite symptom directions as equivalent; weight gain or loss, and increased or decreased sleep, each count toward a single diagnosis. We defined three subgroups of individuals meeting criteria for MDD: AERS+ (hypersomnia with increased appetite/weight gain), AERS- (insomnia with appetite/weight loss), and an Uncategorized group, and conducted genome-wide association meta-analyses for each (N_eff = 47,858, 156,624, and 215,828, respectively). We identified 27 genome-wide significant loci across subtypes, 4 for AERS+, 10 for AERS- and 13 for Uncategorized. AERS+ showed higher SNP-based heritability (10.9%) and lower polygenicity (1.7% of SNPs) than AERS- (7.9%; 2.9%) or Uncategorized (8.6%; 5.3%), with larger effect sizes at its associated loci. The AERS+ and AERS- subtypes were moderately genetically correlated (r_g= 0.64, se = 0.04). Metabolic traits emerged as a primary differentiator: AERS+ correlated positively with BMI, metabolic syndrome, and related traits, whereas AERS- correlated weakly in the opposite direction. These findings show that the directionality of neurovegetative symptoms indexes genetic heterogeneity within MDD, with metabolic biology as a central axis of differentiation.
]]></description>
<dc:creator><![CDATA[ Harder, A., Wang, R., Bergstedt, J., Huider, F., Kurvits, S., Thorp, J., Gong, T., Assary, E., Thijssen, A. B., Merola, G. P., Goula, A. A., Bentwood, S., Karlsson, R., Pasman, J. A., Fabbri, C., Hickie, I. B., Peyrot, W. J., Levinson, D. F., Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium,, Potash, J. B., Shi, J., Medland, S. E., Mitchell, B. L., Kwong, A. S. F., Eley, T. C., Lewis, C. M., Hamilton, S. P., Martin, N. G., Boomsma, D. I., Lehto, K., Wray, N. R., Breen, G., Penninx, B. W. J. H., Milaneschi, Y., Marshall, S., Thomson, P. A., Lu, Y. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26357101</dc:identifier>
<dc:title><![CDATA[Atypical energy-related symptoms define biologically distinct subtypes of major depressive disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.02.26357123v1?rss=1">
<title>
<![CDATA[
PD-L1-linked spatial decoupling of tumour-immune interactions in EBV-positive DLBCL 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.02.26357123v1?rss=1
</link>
<description><![CDATA[
EBV-positive diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma enriched in elderly patients, in which PD-L1 genomic gains cooperate with viral signalling to promote immune escape. However, the spatial mechanisms by which PD-L1 reshapes the tumour microenvironment remain unresolved. Here, we integrate genomic profiling with spatial transcriptomics, spatial proteomics, and single-cell RNA sequencing to resolve the tumour-immune architecture of EBV-positive DLBCL. PD-L1 gain tumours exhibit a striking decoupling of immune proximity and immune engagement: T cells accumulate in close proximity to tumour cells yet direct tumour-immune contact is largely absent. Tumour boundaries are enriched for cancer-associated fibroblasts and display transcriptional signatures of metabolic immune suppression, while tumour-proximal T cells exhibit pronounced exhaustion. Together, these findings reveal a PD-L1 driven spatial immune evasion architecture that permits immune infiltration while enforcing multilayered suppression through fibroblast-mediated exclusion, metabolic constraint, and T-cell dysfunction, ultimately preventing effective anti-tumour immunity in EBV-positive DLBCL.
]]></description>
<dc:creator><![CDATA[ Kunstner, A., Kuemmel, M., Faehnrich, A., Derer, S., Raschdorf, A., Witte, H. M., Maluje, Y., Faerber, B., Roesner, T., Michelson, L., Stiller, F., Merz, M. M., Bernard, V., Stoelting, S., Kolbe, D., Peter, W., Merz, H., von Bubnoff, N., Feller, A. C., Busch, H., Lohneis, P., Gebauer, N. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.02.26357123</dc:identifier>
<dc:title><![CDATA[PD-L1-linked spatial decoupling of tumour-immune interactions in EBV-positive DLBCL]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357062v1?rss=1">
<title>
<![CDATA[
Protocol for a Modified Delphi Consensus Study on the * Clinical Assessment of Children with Suspected Olfactory Dysfunction 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357062v1?rss=1
</link>
<description><![CDATA[
Background Olfactory dysfunction (OD) affects approximately 22% of the general population, yet children account for only around 2% of specialist olfactory clinic attendees -- a striking disparity that likely reflects systematic under-detection rather than lower disease prevalence. There are currently no internationally endorsed clinical guidelines governing the assessment of children with suspected OD. A recent international survey of 167 paediatric otolaryngologists across 36 countries found that more than half never perform psychophysical olfactory testing, a majority routinely order neuroimaging, and that multidisciplinary collaboration is largely lacking - findings that collectively motivate this consensus effort. Materials and Methods This is a prospectively registered, multi-round modified Delphi consensus study. A steering committee of seven international experts spanning paediatric otorhinolaryngology, chemosensory science, neuropaediatrics, and research methodology will generate an initial set of candidate consensus statements across 12 pre-defined clinical domains, derived from a structured narrative evidence review and practice-gap data. A panel of 15-25 international experts will vote anonymously over two to three sequential rounds using a 9-point Likert scale. Consensus is defined a priori as a median score [&ge;]7 with [&ge;]75% of panellists rating 7-9 and an IQR of [&le;]2. A post-Delphi virtual ratification meeting will follow voting rounds. Patient and Public Involvement (PPI) is embedded throughout: a family advisory group of 4-6 parents, caregivers, and young people with lived experience of paediatric OD, recruited in partnership with anosmie.org, will review candidate statements before Round 1, and PPI findings will inform statement framing before expert voting begins. This study was assessed using the Health Research Authority (HRA) online decision tool for England and found not to require NHS Research Ethics Committee (REC) review. The study will be conducted in accordance with the Research Governance Framework for Health and Social Care (2nd Edition). Discussion The final consensus statements and supporting methodology will be submitted for peer-reviewed publication. The study will be reported in compliance with the ACCORD and DELPHISTAR reporting standards for consensus methods. The protocol has been pre-registered prospectively on the Open Science Framework (OSF) prior to data collection.
]]></description>
<dc:creator><![CDATA[ Bhargava, E. K., Whitcroft, K. L., Gellrich, J., Fishman, G., Propst, E. J., Zou, L., Hummel, T. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357062</dc:identifier>
<dc:title><![CDATA[Protocol for a Modified Delphi Consensus Study on the * Clinical Assessment of Children with Suspected Olfactory Dysfunction]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.07.01.26357068v1?rss=1">
<title>
<![CDATA[
Expert perspectives on improving services for patients with periprosthetic femoral fractures: a qualitative study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.07.01.26357068v1?rss=1
</link>
<description><![CDATA[
Background The incidence of post-operative periprosthetic femoral fractures (POPFFs) is increasing. However, specific clinical guidance relating to patient management does not exist, resulting in variations in care and outcomes. This study aimed to elicit and synthesise expert knowledge in POPFF service delivery and explore views on variations in service provision and the factors influencing these. Methods Semi-structured interviews were undertaken with healthcare professionals with expertise in POPFF care from England and Wales to explore current practices, challenges, service variations and perceived future opportunities. Participants were identified through specialist research and clinical networks for POPFF and hip fracture care, authors of key publications on the subject, national leads for POPFF/hip fracture networks, and research team contacts. Interviews were analysed using thematic analysis. Results Ten interviews were undertaken with experts in POPFF services across a range of professional roles. Four themes were identified: conceptualisation of POPFF (by different professional groups and in different service settings) and understanding of POPFF patient needs; sources of variation in management and care of POPFF patients; service model rationales, advantages and disadvantages; and potential strategies to improve POPFF care. Conclusion When designing POPFF services, we suggest that four key areas need consideration: the extent to which POPFF patients are a distinct group with particular care needs; the necessity for and consequences of patient transfer between wards and hospitals; the resourcing of extensive multidisciplinary support for POPFF patients; and the need for national initiatives to encourage service developments. These findings should form the basis of future clinical guidance. Sensitivity to contextual factors driving variation in services is needed to ultimately improve care for POPFF patients.
]]></description>
<dc:creator><![CDATA[ Gibson, H., Chekar, C. K., Goodwin, D. K., Shelton, C., Smith, T. O., Johansen, A., Aryaie, M., Muruet, W., Reed, M., Evans, J. T., Whitehouse, M., Baxter, M., Bottle, A., Benn, J. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.07.01.26357068</dc:identifier>
<dc:title><![CDATA[Expert perspectives on improving services for patients with periprosthetic femoral fractures: a qualitative study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.06.25.26356547v1?rss=1">
<title>
<![CDATA[
Shared decision-making about uveal melanoma treatment in the Netherlands: non-neutral framing of medical information 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.06.25.26356547v1?rss=1
</link>
<description><![CDATA[
Background: A subset of uveal melanomas can be treated using either enucleation or proton beam therapy (PBT), which offer similar oncological outcomes. The most appropriate treatment depends on a patient's preference. To allow patients to genuinely determine their preference, it is recommended to describe options as neutrally as possible. This study assesses to what extent ocular oncologists use and perceive non-neutral framing behaviour, and if it is related to patient satisfaction with decision-making. Methods: Consultations of ocular oncologists with patients newly-diagnosed with uveal melanoma were audio recorded, transcribed verbatim, and coded for ocular oncologists' explicit and implicit non-neutral framing behaviours. Explicit non-neutral framing was defined as: explicitly mentioning a preferred option at least once, without relating it to the patient. Implicit non-neutral framing was defined as: describing an option (un)favourably, without providing a medically substantive clarification alongside. Results: 110 patients provided consent for the audio recordings. Non-neutral framing was found in 84% (n=92/110) of consultations. We found explicit behaviour in 38% (42/110) and implicit behaviour in 76% (84/110, median=1, range, 0-4) of consultations. The most frequent implicit framing was presenting options by positively or negatively emphasizing one option. Non-neutral framing behaviours were not significantly related to patient satisfaction with decision-making. Conclusion: This study shows that in most consultations some non-neutral framing was present, which did not impact patients' satisfaction with decision-making. Nonetheless, ocular oncologists should be aware that how they describe options may influence preferences in ways that do not align with the patient's values.
]]></description>
<dc:creator><![CDATA[ Shirzada, A., Vlug, L., Marinkovic, M., Luyten, G. P. M., Bleeker, J. C., Vu, T. H. K., Rasch, C. R. N., Horeweg, N., Pieterse, A. ]]></dc:creator>
<dc:date>2026-07-04</dc:date>
<dc:identifier>doi:10.64898/2026.06.25.26356547</dc:identifier>
<dc:title><![CDATA[Shared decision-making about uveal melanoma treatment in the Netherlands: non-neutral framing of medical information]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
